Christian Winther Eskelund, MD, Copenhagen University Hospital, Rigshospitalet, discusses outcomes for patients with TP53-mutated mantle cell lymphoma (MCL).
Christian Winther Eskelund, MD
Advertisement
Articles by Christian Winther Eskelund, MD
Christian Winther Eskelund, MD, Copenhagen University Hospital, Rigshospitalet, discusses TP53-mutated mantle cell lymphoma (MCL).
Christian Winther Eskelund, MD, Copenhagen University Hospital, Rigshospitalet, discusses a study of TP53 mutations in mantle cell lymphoma.
Advertisement
Latest Updated Articles
Dr. Eskelund Discusses TP53 Mutated Mantle Cell LymphomaPublished: June 28th 2017 | Updated:
Dr. Eskelund on Outcomes of TP53-Mutated MCLPublished: October 11th 2017 | Updated:
Dr. Eskelund on Study of TP53 Mutations in Mantle Cell LymphomaPublished: June 24th 2017 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
3
The OncFive: Top Oncology Articles for the Week of 1/25
4
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
5